vindesine has been researched along with Adverse Drug Event in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, T; Li, Z; Qiu, X; Sun, K; Tao, H; Wu, Z; Zhong, M | 1 |
| Anglaret, B; Bologna, S; Bonnet, C; Bordessoule, D; Brière, J; Casasnovas, O; Christian, B; Coiffier, B; Connerotte, T; Delarue, R; Fabiani, B; Fermé, C; Fruchart, C; Haioun, C; Ketterer, N; Morschhauser, F; Récher, C; Soussain, C; Thieblemont, C; Tilly, H | 1 |
| Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F | 1 |
2 trial(s) available for vindesine and Adverse Drug Event
| Article | Year |
|---|---|
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Rituximab; Treatment Outcome; Vindesine | 2013 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Pilot Projects; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2006 |
1 other study(ies) available for vindesine and Adverse Drug Event
| Article | Year |
|---|---|
Risk factors for high-dose methotrexate associated toxicities in patients with primary central nervous system lymphoma.
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Central Nervous System; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Humans; Lymphoma; Methotrexate; Risk Factors; Vindesine | 2022 |